Prospective on Imaging Mass Spectrometry in Clinical Diagnostics
Molecular & Cellular Proteomics · 2023-09 · 22 (9) · 100576
DOI: 10.1016/j.mcpro.2023.100576 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular & Cellular Proteomics, 2023-09. Verfasst von Jessica L Moore und 3 weiteren Autor:innen. Beteiligte Einrichtung: Frontier Diagnostics, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Reproducibility of Results. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, VANDERBILT UNIVERSITY, National Institutes of Health.
Abstract (Originalsprache)
Imaging mass spectrometry (IMS) is a molecular technology utilized for spatially driven research, providing molecular maps from tissue sections. This article reviews matrix-assisted laser desorption ionization (MALDI) IMS and its progress as a primary tool in the clinical laboratory. MALDI mass spectrometry has been used to classify bacteria and perform other bulk analyses for plate-based assays for many years. However, the clinical application of spatial data within a tissue biopsy for diagnoses and prognoses is still an emerging opportunity in molecular diagnostics. This work considers spatially driven mass spectrometry approaches for clinical diagnostics and addresses aspects of new imaging-based assays that include analyte selection, quality control/assurance metrics, data reproducibility, data classification, and data scoring. It is necessary to implement these tasks for the rigorous translation of IMS to the clinical laboratory; however, this requires detailed standardized protocols for introducing IMS into the clinical laboratory to deliver reliable and reproducible results that inform and guide patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Frontier Diagnostics, Nashville, Tennessee, USA.
- Frontier Diagnostics, Nashville, Tennessee, USA; Vanderbilt University Mass Spectrometry Research Center, Vanderbilt University, Nashville, Tennessee, USA.
- Frontier Diagnostics, Nashville, Tennessee, USA; Vanderbilt University Mass Spectrometry Research Center, Vanderbilt University, Nashville, Tennessee, USA; Departments of Biochemistry, Pharmacology, Chemistry, and Medic…
Förderung
- NIDDK NIH HHS
- VANDERBILT UNIVERSITY
- National Institutes of Health
Zitieren
APA
Moore, J. L., Patterson, N. H., Norris, J. L., & Caprioli, R. M. (2023). Prospective on Imaging Mass Spectrometry in Clinical Diagnostics. Molecular & Cellular Proteomics, 22(9), 100576. https://doi.org/10.1016/j.mcpro.2023.100576
Vancouver
Moore JL, Patterson NH, Norris JL, Caprioli RM. Prospective on Imaging Mass Spectrometry in Clinical Diagnostics. Molecular & Cellular Proteomics. 2023;22(9):100576. doi:10.1016/j.mcpro.2023.100576
BibTeX
@article{Moore2023,
author = {Moore, Jessica L and Patterson, Nathan Heath and Norris, Jeremy L and Caprioli, Richard M},
title = {Prospective on Imaging Mass Spectrometry in Clinical Diagnostics},
journal = {Molecular & Cellular Proteomics},
year = {2023},
volume = {22},
number = {9},
pages = {100576},
doi = {10.1016/j.mcpro.2023.100576}
}
EUVIMED